Press Release: Stealth : Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application

- FDA decision on elamipretide for the treatment of Barth syndrome delayed -- Labelling discussions underway, but no revised action date communicated by FDA...